DJIA 16,614.81 0.00 0.00%
NASDAQ 4,419.48 0.00 0.00%
S&P 500 1,941.28 0.00 0.00%
market minute promo

MannKind Corp (NASDAQ: MNKD)

5.53 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $5.50 -$0.03 (-0.54%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

MNKD $5.53 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.41
Previous Close $5.53
Daily Range $5.38 - $5.53
52-Week Range $3.80 - $11.48
Market Cap $2.2B
P/E Ratio -8.12
Dividend (Yield) $0.00 (0.0%)
Volume 3,509,003
Average Daily Volume 6,433,651
Current FY EPS -$0.33

Sector

Healthcare

Industry

Drugs

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/

News & Commentary

MannKind Corporation's Investors Shouldn't Dance Around This Issue

It's not a good sign that MannKind's competitor can't IPO.

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

MannKind: 5 Potential Technosphere Applications

Discovery Laboratories: Collaboration With Battelle Is Validation Of Aerosurf's Potential By A Sophi

Discovery Laboratories: Collaboration With Battelle Is Validation Of Aerosurf's Potential By A Sophisticated Third Party

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

MannKind (MNKD) Worth Watching: Stock Gains 12.9% - Tale of the Tape

Dance until the music stops: Insulin biotech Dance Biopharm withdraws $75 million IPO

The State Of MannKind

MannKind: Technosphere Is The Real Game Changer

MNKD January 2017 Options Begin Trading

See More MNKD News...

MNKD's Top Competitors

MNKD $5.53 (0.00%)
Current stock: MNKD
AMGN $144.09 (0.00%)
Current stock: AMGN
GILD $106.67 (0.00%)
Current stock: GILD
BIIB $326.77 (0.00%)
Current stock: BIIB